About Tenet Healthcare (NYSE:THC)
Tenet Healthcare Corporation (Tenet) is a healthcare services company. The Company operates regionally focused, integrated healthcare delivery networks in large urban and suburban markets in the United States. The Company's segments include Hospital Operations and Other, Ambulatory Care and Conifer. As of December 31, 2016, its subsidiaries operated 79 hospitals, including three academic medical centers, two children's hospitals, two specialty hospitals and one critical access hospital. The Company's Ambulatory Care segment includes the operations of its USPI joint venture and its Aspen facilities. As of December 31, 2016, Conifer provided one or more of the business process services described above from 20 service centers to more than 800 Tenet and non-Tenet hospital and other clients in over 40 states. As of December 31, 2016, the Company operated 20 short-stay surgical hospitals, over 470 outpatient centers, and nine facilities in the United Kingdom.
Industry, Sector and Symbol
Industry MEDICAL CARE
Sub-IndustryHealth Care Facilities
Trailing P/E Ratio-3.54363376251788
Forward P/E Ratio26.92
Sales & Book Value
Annual Sales$19.18 billion
Price / Sales0.13
Cash Flow$10.15 per share
Price / Cash2.44
Book Value$5.34 per share
Price / Book4.64
Return on Equity9.69%
Return on Assets0.34%
Tenet Healthcare (NYSE:THC) Frequently Asked Questions
What is Tenet Healthcare's stock symbol?
Tenet Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "THC."
How were Tenet Healthcare's earnings last quarter?
Tenet Healthcare Corp (NYSE:THC) posted its earnings results on Monday, February, 26th. The company reported $1.40 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.25 by $0.15. The business had revenue of $4.98 billion for the quarter, compared to analyst estimates of $4.85 billion. Tenet Healthcare had a negative net margin of 3.67% and a positive return on equity of 9.69%. Tenet Healthcare's revenue was up 2.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.06 EPS. View Tenet Healthcare's Earnings History.
When will Tenet Healthcare make its next earnings announcement?
What guidance has Tenet Healthcare issued on next quarter's earnings?
Tenet Healthcare issued an update on its FY18 earnings guidance on Monday, February, 26th. The company provided EPS guidance of $0.73-$1.07 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.78. The company issued revenue guidance of $17.9-$18.3 billion, compared to the consensus revenue estimate of $18.26 billion.Tenet Healthcare also updated its Q1 guidance to ($0.10)-$0.05 EPS.
Where is Tenet Healthcare's stock going? Where will Tenet Healthcare's stock price be in 2018?
16 brokerages have issued 1-year target prices for Tenet Healthcare's shares. Their predictions range from $15.00 to $30.00. On average, they expect Tenet Healthcare's stock price to reach $21.47 in the next twelve months. View Analyst Ratings for Tenet Healthcare.
Who are some of Tenet Healthcare's key competitors?
Some companies that are related to Tenet Healthcare include Molina Healthcare (MOH), Envision Healthcare (EVHC), Chemed (CHE), Premier (PINC), Healthequity (HQY), Syneos Health (SYNH), Medidata Solutions (MDSO), Acadia Healthcare (ACHC), Foundation Medicine (FMI), Udg Healthcare (UDHCF), AMN Healthcare Services (AMN), Teladoc (TDOC), Magellan Health (MGLN), Select Medical (SEM), Allscripts Healthcare Solutions (MDRX), Intrexon (XON), Amedisys (AMED) and Novocure (NVCR).
Who are Tenet Healthcare's key executives?
Tenet Healthcare's management team includes the folowing people:
- Ronald A. Rittenmeyer, Executive Chairman of the Board, Chief Executive Officer
- Trevor Fetter, President
- Daniel J. Cancelmi, Chief Financial Officer
- J. Eric Evans, President - Hospital Operations
- Sandra R.A. Karrmann, Chief Human Resource Officer, Senior Vice President
- Audrey T. Andrews, Senior Vice President and General Counsel
- James L. Bierman, Independent Director
- John P. Byrnes, Independent Director
- Richard W. Fisher, Independent Director
- Brenda J. Gaines, Independent Director
Has Tenet Healthcare been receiving favorable news coverage?
News headlines about THC stock have trended somewhat negative this week, Accern Sentiment reports. The research group identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Tenet Healthcare earned a news impact score of -0.02 on Accern's scale. They also gave news articles about the company an impact score of 46.07 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
Who are Tenet Healthcare's major shareholders?
Tenet Healthcare's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include
GLENVIEW CAPITAL MANAGEMENT, LLC
GLENVIEW CAPITAL MANAGEMENT, LLC
(17.77%), HealthCor Management L.P. (2.93%), Letko Brosseau & Associates Inc. (1.98%), Brigade Capital Management LP (1.56%) and Millennium Management LLC (1.48%). Company insiders that own Tenet Healthcare stock include Ashish Dave, George Fredrick Smitherman, Peter M Wilver and Ronald A Rittenmeyer. View Institutional Ownership Trends for Tenet Healthcare.
Which institutional investors are selling Tenet Healthcare stock?
THC stock was sold by a variety of institutional investors in the last quarter, including HealthCor Management L.P., UBS Asset Management Americas Inc., SG Americas Securities LLC, Bank of New York Mellon Corp, Hudson Bay Capital Management LP, Metropolitan Life Insurance Co. NY, Jane Street Group LLC and Allianz Asset Management GmbH. Company insiders that have sold Tenet Healthcare company stock in the last year include Ashish Dave and George Fredrick Smitherman. View Insider Buying and Selling for Tenet Healthcare.
Which institutional investors are buying Tenet Healthcare stock?
THC stock was acquired by a variety of institutional investors in the last quarter, including Letko Brosseau & Associates Inc., Millennium Management LLC, Price Michael F, Gotham Asset Management LLC, HBK Investments L P, Brigade Capital Management LP, Deutsche Bank AG and Spark Investment Management LLC. Company insiders that have bought Tenet Healthcare stock in the last two years include George Fredrick Smitherman, Peter M Wilver and Ronald A Rittenmeyer. View Insider Buying and Selling for Tenet Healthcare.
How do I buy shares of Tenet Healthcare?
Shares of THC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Tenet Healthcare's stock price today?
One share of THC stock can currently be purchased for approximately $24.77.
How big of a company is Tenet Healthcare?
Tenet Healthcare has a market capitalization of $2.43 billion and generates $19.18 billion in revenue each year. The company earns $-704,000,000.00 in net income (profit) each year or ($6.99) on an earnings per share basis. Tenet Healthcare employs 126,000 workers across the globe.
How can I contact Tenet Healthcare?
Tenet Healthcare's mailing address is 1445 ROSS AVENUE SUITE 1400, DALLAS TX, 75202. The company can be reached via phone at 469-893-2200 or via email at [email protected]
MarketBeat Community Rating for Tenet Healthcare (THC)MarketBeat's community ratings are surveys of what our community members think about Tenet Healthcare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Tenet Healthcare (NYSE:THC) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Hold||Hold||Hold||Hold|
|Consensus Rating Score: ||2.31||2.21||2.29||2.36|
|Ratings Breakdown: ||2 Sell Rating(s)|
7 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
7 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
|2 Sell Rating(s)|
6 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
|0 Sell Rating(s)|
9 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
|Consensus Price Target: ||$21.47||$18.15||$18.38||$20.75|
|Price Target Upside: ||13.34% downside||4.85% downside||22.32% upside||27.14% upside|
Tenet Healthcare (NYSE:THC) Consensus Price Target History
Tenet Healthcare (NYSE:THC) Analyst Ratings History
(Data available from 3/24/2016 forward)
Tenet Healthcare (NYSE:THC) Earnings History and Estimates Chart
Tenet Healthcare (NYSE THC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/26/2018||Q4 2017||$1.25||$1.40||$4.85 billion||$4.98 billion||View||N/A|
|11/6/2017||Q3 2017||($0.40)||($0.17)||$4.94 billion||$4.59 billion||View||N/A|
|10/27/2017||Q3 2017||($0.38)||($0.17)||$4.73 billion||$4.59 billion||View||N/A|
|8/7/2017||Q2 2017||($0.17)||($0.17)||$4.90 billion||$14.80 billion||View||Listen|
|5/1/2017||Q1 2017||($0.52)||($0.27)||$4.84 billion||$4.81 billion||View||Listen|
|2/27/2017||Q416||$0.22||$0.06||$4.95 billion||$4.86 billion||View||N/A|
|10/31/2016||Q316||$0.17||$0.16||$2.28 billion||$4.85 billion||View||N/A|
|8/1/2016||Q216||$0.52||$0.38||$4.82 billion||$4.87 billion||View||N/A|
|5/2/2016||Q116||$0.34||$0.45||$4.79 billion||$5.04 billion||View||N/A|
|2/22/2016||Q415||$0.34||$0.35||$4.82 billion||$5.21 billion||View||Listen|
|11/2/2015||Q315||$0.27||$0.29||$4.67 billion||$4.69 billion||View||N/A|
|8/3/2015||Q215||$0.44||$0.75||$4.37 billion||$4.49 billion||View||N/A|
|5/4/2015||Q115||$0.31||$0.67||$4.33 billion||$4.43 billion||View||N/A|
|2/23/2015||Q414||$1.18||$1.03||$4.34 billion||$4.82 billion||View||N/A|
|11/3/2014||Q314||$0.10||$0.09||$4.02 billion||$4.18 billion||View||Listen|
|8/4/2014||Q214||$0.01||($0.27)||$3.94 billion||$4.04 billion||View||N/A|
|5/5/2014||Q114||($0.14)||($0.12)||$3.91 billion||$3.93 billion||View||Listen|
|2/24/2014||Q413||$0.37||$0.49||$3.87 billion||$3.89 billion||View||N/A|
|11/5/2013||Q313||$0.45||$0.45||$2.38 billion||$2.62 billion||View||Listen|
|8/6/2013||Q2 2013||$0.75||($0.49)||$2.46 billion||$2.42 billion||View||N/A|
|4/30/2013||Q1 2013||$0.31||$0.33||$2.46 billion||$2.59 billion||View||Listen|
|2/26/2013||Q4 2012||$0.68||$0.45||$2.34 billion||$2.33 billion||View||Listen|
|11/7/2012||Q312||$0.32||$0.34||$2.42 billion||$2.43 billion||View||N/A|
Tenet Healthcare (NYSE:THC) Earnings Estimates
2018 EPS Consensus Estimate: $0.94
2019 EPS Consensus Estimate: $1.74
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Tenet Healthcare (NYSE:THC)
No dividend announcements for this company have been tracked by MarketBeat.com
Tenet Healthcare (NYSE THC) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.10%
Tenet Healthcare (NYSE THC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/5/2018||George Fredrick Smitherman||Director||Sell||39,000||$0.39||$15,210.00|
|1/30/2018||George Fredrick Smitherman||Director||Sell||14,300||$2.02||$28,886.00|
|1/25/2018||George Fredrick Smitherman||Director||Buy||125,000||$38.50||$4,812,500.00|
|1/15/2018||George Fredrick Smitherman||Director||Sell||1,300||$38.50||$50,050.00|
|11/11/2016||Ronald A Rittenmeyer||Director||Buy||15,000||$14.35||$215,250.00||23,783|| |
|11/9/2016||Peter M Wilver||Director||Buy||5,000||$15.19||$75,950.00||5,000|| |
|11/13/2015||Glenview Capital Management, L||Major Shareholder||Buy||900,000||$32.56||$29,304,000.00|| |
|10/22/2015||Glenview Capital Management, L||Major Shareholder||Buy||500,000||$29.71||$14,855,000.00|| |
|9/30/2015||Glenview Capital Management, L||Major Shareholder||Buy||500,000||$36.30||$18,150,000.00|| |
|8/25/2015||Glenview Capital Management, L||Major Shareholder||Buy||500,000||$48.39||$24,195,000.00|| |
|7/14/2015||Trevor Fetter||CEO||Sell||96,477||$60.40||$5,827,210.80|| |
|7/13/2015||Trevor Fetter||CEO||Sell||88,004||$60.08||$5,287,280.32|| |
|7/6/2015||Trevor Fetter||CEO||Sell||83,443||$60.02||$5,008,248.86|| |
|6/25/2015||Glenview Capital Management, L||Major Shareholder||Buy||979,482||$54.93||$53,802,946.26|| |
|6/25/2015||Trevor Fetter||CEO||Sell||47,711||$55.02||$2,625,059.22|| |
|6/4/2015||R. Scott Ramsey||Insider||Sell||5,650||$51.64||$291,766.00|| |
|8/18/2014||Trevor Fetter||CEO||Sell||33,642||$60.01||$2,018,856.42|| |
|8/14/2014||Britt T Reynolds||Insider||Sell||8,028||$58.49||$469,557.72|| |
|8/8/2014||Audrey T Andrews||SVP||Sell||2,208||$56.31||$124,332.48|| |
|8/8/2014||Daniel J Cancelmi||CFO||Sell||12,291||$56.88||$699,112.08|| |
|8/8/2014||R. Scott Ramsey||Insider||Sell||2,083||$56.27||$117,210.41|| |
|8/7/2014||Trevor Fetter||CEO||Sell||138,665||$56.12||$7,781,879.80|| |
|7/25/2014||Trevor Fetter||CEO||Sell||41,000||$51.34||$2,104,940.00|| |
|6/9/2014||Britt T Reynolds||Insider||Sell||35,000||$49.82||$1,743,700.00|| |
|5/22/2014||Trevor Fetter||CEO||Sell||35,394||$47.52||$1,681,922.88||963,790|| |
|5/15/2014||Richard Pettingill||Director||Sell||10,000||$45.22||$452,200.00||16,464|| |
|5/12/2014||Edward Kangas||Chairman||Sell||12,000||$44.29||$531,480.00||24,198|| |
|4/25/2014||Trevor Fetter||CEO||Sell||57,735||$45.00||$2,598,075.00||999,184|| |
|3/24/2014||Audrey Andrews||SVP||Sell||13,624||$40.17||$547,276.08|| |
|12/23/2013||Glenview Capital Management, L||major shareholder||Buy||248,910||$39.79||$9,904,128.90|| |
|12/20/2013||Glenview Capital Management, L||major shareholder||Buy||644,582||$39.95||$25,751,050.90|| |
|12/18/2013||Glenview Capital Management, L||major shareholder||Buy||1,000,000||$40.12||$40,120,000.00|| |
|11/15/2013||Keith Pitts||Chairman||Buy||6,250||$43.13||$269,562.50||25,000|| |
|11/14/2013||Keith Pitts||Chairman||Buy||6,250||$43.14||$269,625.00||18,750|| |
|11/8/2013||Keith Pitts||Chairman||Buy||7,500||$41.85||$313,875.00||12,500|| |
|11/7/2013||Keith Pitts||Chairman||Buy||5,000||$41.97||$209,850.00||5,000|| |
|10/3/2013||John Ellis Bush||Director||Sell||16,582||$45.10||$747,848.20|| |
|9/19/2013||John Ellis Bush||Director||Sell||8,291||$42.90||$355,683.90||36,913|| |
|5/14/2013||Glenview Capital Management, L||Major Shareholder||Sell||4,000,000||$47.75||$191,000,000.00|| |
|3/5/2013||Edward A Kangas||Chairman||Sell||7,000||$39.88||$279,160.00|| |
|3/4/2013||Trevor Fetter||CEO||Sell||138,255||$39.39||$5,445,864.45|| |
|10/19/2012||Glenview Capital Management Ll||Major Shareholder||Buy||200,000||$23.53||$4,706,000.00|| |
|10/16/2012||Glenview Capital Management Ll||Major Shareholder||Buy||433,383||$23.98||$10,392,524.34|| |
|9/17/2012||Glenview Capital Management Ll||Major Shareholder||Buy||750,000||$5.75||$4,312,500.00|| |
Tenet Healthcare (NYSE THC) News Headlines
Tenet Healthcare (NYSE:THC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Tenet Healthcare (NYSE:THC) Income Statement, Balance Sheet and Cash Flow Statement
Tenet Healthcare (NYSE THC) Stock Chart for Saturday, March, 24, 2018